Unknown NA INTERVENTIONAL 2-arm NCT03807388

ReMindCare App for Patients From First Episode of Psychosis Unit.

The Use of ReMindCare Application for Smartphone in Treatment of Patients From First Episode of Psychosis Unit in the Clinic Hospital of Valencia, Spain.

Sponsor: Hospital Clínico Universitario de Valencia

Conditions Adherence, Medication Delirium Hallucinations Psychosis Psychotic Disorders Schizophrenia Treatment Side Effects

Interventions ReMindCare Intervention Group Treatment as Usual

Updated 7 times since 2019 Last updated: Jan 15, 2019 Started: Sep 30, 2019 Primary completion: May 31, 2020 Completion: Sep 30, 2023

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A NA clinical study on Adherence, Medication and Delirium, this trial is ongoing. The trial is conducted by Hospital Clínico Universitario de Valencia and has accumulated 7 data snapshots since 2019. Psychiatric clinical trials are essential for establishing evidence-based treatment standards.

Status Flow

Change History

7 versions recorded

Oct 2025 — Present [monthly]

Unknown NA
Sep 2024 — Oct 2025 [monthly]

Unknown NA
Jul 2024 — Sep 2024 [monthly]

Unknown NA

Status: Unknown Status → Unknown
Oct 2023 — Jul 2024 [monthly]

Unknown Status NA

Status: Not Yet Recruiting → Unknown Status
Jan 2021 — Oct 2023 [monthly]

Not Yet Recruiting NA

▶ Show 2 earlier versions

Mar 2019 — Jan 2021 [monthly]

Not Yet Recruiting NA
Feb 2019 — Mar 2019 [monthly]

Not Yet Recruiting NA

First recorded

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Hospital Clínico Universitario de Valencia
Instituto de Investigacion Sanitaria INCLIVA
Universitat Politècnica de València
University of Valencia

Data source: Instituto de Investigacion Sanitaria INCLIVA

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Valencia, Spain